Clinical Trials Directory

Trials / Sponsors / Exosome Diagnostics, Inc.

Exosome Diagnostics, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
UnknownExoDx Prostate Evaluation in Active Surveillance Patient Population
Prostate Cancer
—2022-10-01
UnknownUrine Biomarker for Kidney Transplant Rejection
Graft Rejection
—2021-10-01
CompletedClinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
Urologic Cancer
—2020-06-01
TerminatedExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
Prostate Cancer
—2020-03-15
UnknownDecision Impact Trial of the ExoDx Prostate (IntelliScore)
Cancer of the Prostate
N/A2017-07-19
CompletedClinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Cancer of Prostate
—2016-09-01
SuspendedDetection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Metastatic Castrate Resistant Prostate Cancer
—2016-02-01
UnknownDetection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCL
Carcinoma, Non-Small-Cell Lung
—2015-03-01
CompletedClinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer
Prostate Cancer
—2014-05-01